217 related articles for article (PubMed ID: 32235232)
21. Papilledema Outcomes from the Optical Coherence Tomography Substudy of the Idiopathic Intracranial Hypertension Treatment Trial.
;
Ophthalmology; 2015 Sep; 122(9):1939-45.e2. PubMed ID: 26198807
[TBL] [Abstract][Full Text] [Related]
22. OCT for optic disc evaluation in idiopathic intracranial hypertension.
Skau M; Milea D; Sander B; Wegener M; Jensen R
Graefes Arch Clin Exp Ophthalmol; 2011 May; 249(5):723-30. PubMed ID: 20949278
[TBL] [Abstract][Full Text] [Related]
23. [Optic disc changes by optical coherence tomography in optic disc edema in Lomé].
Santos MAK; Vonor K; Ayena DK; Kuaovi KR; Balo KP
J Fr Ophtalmol; 2017 Apr; 40(4):314-318. PubMed ID: 28336281
[TBL] [Abstract][Full Text] [Related]
24. Differentiating mild papilledema and buried optic nerve head drusen using spectral domain optical coherence tomography.
Kulkarni KM; Pasol J; Rosa PR; Lam BL
Ophthalmology; 2014 Apr; 121(4):959-63. PubMed ID: 24321144
[TBL] [Abstract][Full Text] [Related]
25. The Relationship Between Optic Disc Volume, Area, and Frisén Score in Patients With Idiopathic Intracranial Hypertension.
Sheils CR; Fischer WS; Hollar RA; Blanchard LM; Feldon SE;
Am J Ophthalmol; 2018 Nov; 195():101-109. PubMed ID: 30081012
[TBL] [Abstract][Full Text] [Related]
26. Diagnosis and grading of papilledema in patients with raised intracranial pressure using optical coherence tomography vs clinical expert assessment using a clinical staging scale.
Scott CJ; Kardon RH; Lee AG; Frisén L; Wall M
Arch Ophthalmol; 2010 Jun; 128(6):705-11. PubMed ID: 20547947
[TBL] [Abstract][Full Text] [Related]
27. Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part I: quality control, comparisons, and variability.
; Auinger P; Durbin M; Feldon S; Garvin M; Kardon R; Keltner J; Kupersmith M; Sibony P; Plumb K; Wang JK; Werner JS
Invest Ophthalmol Vis Sci; 2014 Nov; 55(12):8180-8. PubMed ID: 25370510
[TBL] [Abstract][Full Text] [Related]
28. Lamina cribrosa surface position in idiopathic intracranial hypertension with swept-source optical coherence tomography.
Pasaoglu I; Satana B; Altan C; Artunay O; Basarir B; Onmez FE; Inal A
Indian J Ophthalmol; 2019 Jul; 67(7):1085-1088. PubMed ID: 31238417
[TBL] [Abstract][Full Text] [Related]
29. Optical coherence tomography features and correlation of functional and structural parameters in patients of idiopathic intracranial hypertension.
Banerjee M; Phuljhele S; Saluja G; Kumar P; Saxena R; Sharma P; Vibha D; Pandit AK
Indian J Ophthalmol; 2022 Apr; 70(4):1343-1349. PubMed ID: 35326052
[TBL] [Abstract][Full Text] [Related]
30. Can Lumbar Puncture Be Safely Deferred in Patients With Mild Presumed Idiopathic Intracranial Hypertension?
Vosoughi AR; Margolin EA; Micieli JA
J Neuroophthalmol; 2022 Dec; 42(4):505-508. PubMed ID: 34860748
[TBL] [Abstract][Full Text] [Related]
31. SD-OCT to distinguish papilledema from pseudopapilledema.
Asensio-Sánchez VM; Trujillo-Guzmán L
Arch Soc Esp Oftalmol; 2015 Oct; 90(10):481-3. PubMed ID: 26148443
[TBL] [Abstract][Full Text] [Related]
32. Peripapillary microperimetry for the diagnosis and follow-up of papilledema in cases treated for idiopathic intracranial hypertension.
Elnahry GA; Elemary AM; Badr Eldin N; Nossair AA; Barrada OA; Elnahry AG
Neurol Res; 2021 Jan; 43(1):61-70. PubMed ID: 32915708
[TBL] [Abstract][Full Text] [Related]
33. A Deep-Learning Approach for Automated OCT En-Face Retinal Vessel Segmentation in Cases of Optic Disc Swelling Using Multiple En-Face Images as Input.
Islam MS; Wang JK; Johnson SS; Thurtell MJ; Kardon RH; Garvin MK
Transl Vis Sci Technol; 2020 Mar; 9(2):17. PubMed ID: 32821471
[TBL] [Abstract][Full Text] [Related]
34. Use of optical coherence tomography to evaluate papilledema and pseudopapilledema.
Heidary G; Rizzo JF
Semin Ophthalmol; 2010; 25(5-6):198-205. PubMed ID: 21091000
[TBL] [Abstract][Full Text] [Related]
35. Neuro-ophthalmological evaluation including optical coherence tomography surrounding venous sinus stenting in idiopathic intracranial hypertension with papilledema: a case series.
Hendrix P; Whiting CJ; Griessenauer CJ; Bohan C; Schirmer CM; Goren O
Neurosurg Rev; 2022 Jun; 45(3):2239-2247. PubMed ID: 35067804
[TBL] [Abstract][Full Text] [Related]
36. Venous Sinus Stenting in Idiopathic Intracranial Hypertension: Results of a Prospective Trial.
Dinkin MJ; Patsalides A
J Neuroophthalmol; 2017 Jun; 37(2):113-121. PubMed ID: 27556959
[TBL] [Abstract][Full Text] [Related]
37. Management of the regression of papilledema with regional axon loss in idiopathic intracranial hypertension patients.
Kabatas N; Eren Y; Nalcacioglu P; Caliskan S; Bicer T; Comoglu SS; Gurdal C
Int Ophthalmol; 2021 Apr; 41(4):1467-1477. PubMed ID: 33481155
[TBL] [Abstract][Full Text] [Related]
38. Quantitative analysis of optic nerve damage in idiopathic intracranial hypertension (IIH) at diagnosis.
Marzoli SB; Ciasca P; Curone M; Cammarata G; Melzi L; Criscuoli A; Bussone G; D'Amico D
Neurol Sci; 2013 May; 34 Suppl 1():S143-5. PubMed ID: 23695066
[TBL] [Abstract][Full Text] [Related]
39. [Utility of optic coherence tomography (OCT) in the follow-up of idiopathic intracranial hypertension in childhood].
Sánchez-Tocino H; Bringas R; Iglesias D; González-Pérez A; Del Villar-Galán R
Arch Soc Esp Oftalmol; 2006 Jul; 81(7):383-9. PubMed ID: 16888691
[TBL] [Abstract][Full Text] [Related]
40. Relationship Between Pattern Electroretinogram, Frequency-Domain OCT, and Automated Perimetry in Chronic Papilledema From Pseudotumor Cerebri Syndrome.
Afonso CL; Raza AS; Kreuz AC; Hokazono K; Cunha LP; Oyamada MK; Monteiro ML
Invest Ophthalmol Vis Sci; 2015 Jun; 56(6):3656-65. PubMed ID: 26047166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
